← Eichor
Study identifier: NCT05948904 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.

Condition: Lung Diseases  ·  Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Developing a standardized methodology for the use of novel cryogenic catheters for transbronchial cryobiopsy and cryoablation of pulmonary lesions.

This description comes directly from the study's public registry record.

Talk to the study team

Moishe Liberman, MD  ·  514-890-8000  ·  moishe.liberman@umontreal.ca

Adeline Jouquan, MSc  ·  514-890-8000  ·  adeline.jouquan.chum@ssss.gouv.qc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

CHUMMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05948904